“Earlier this year, the F.D.A. issued a warning to Ambrosia, a company that was selling plasma transfusions of ‘young blood’ to elderly people, suggesting it may stop aging. While the F.D.A. announced there is ‘no proven clinical benefit’ of these transfusions, it’s not the first time the practice has been pursued: Stanford researchers published a study on young blood transfusions 2017.” Read the full story at Beingpatient.com
‘Young Blood’ Researchers Are Still in the Pursuit to Stall Aging, Slow Alzheimer’s | Being Patient
More from Current EventMore posts in Current Event »
- Failure of once-promising Alzheimer’s drug reinforces doubts about amyloid beta | Med City News
- Former NFL Wife on Her Husband’s Battle with CTE
- Capito, Collins introduce bill to increase awareness of Alzheimer’s services | Ripon Advance
- ‘It is not alarmist to say that the people of Florida are being slowly poisoned by the water’ | Opinion | Miami Herald
- NYPD Blue and Deadwood Creator David Milch Reveals He Has Been Diagnosed with Alzheimer’s Disease | People